Intra Cellular Therapies | Brutto Fortjeneste På Salg

Gross Profit On Sales Endring Dato
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
Halozyme Therapeutics USD 177.74M 16.53M 2023-12
Intra Cellular Therapies USD 121.4M 4.35M 2023-12
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
RedHill Biopharma USD 990K 997K 2023-06
Supernus Pharmaceuticals USD 144.69M 10.41M 2023-12
United Therapeutics USD 543.7M 4.4M 2023-12



Intra Cellular Therapies Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.